• Hosts:
  • CN-Healthcare Media
  • Chinese Research Hospital Association
  • Health and Family Planning Commission of Hainan Province
  • The People's Government of Qionghai City (Hainan Province, China)
  • Co-hosts:
  • China Federation for Hospital Quality Control Circle
  • China Medical Innovation Alliance
  • Chinese Non-Government Medical Institutions Association
  • Institute for Hospital Management of Tsinghua University
  • Academic Collaborators:
  • West China Hospital, Sichuan University
  • Zhongshan Hospital, Fudan University
  • Peking University Third Hospital
  • Xiangya Hospital Central South University
  • Media Collaborator: China.org.cn/China.com.cn
  • International Cooperators:
  • Mayo Clinic
  • New York-Presbyterian Hospital
  • University of Pittsburgh Medical Center
  • Houston Methodist Hospital
  • Greater Paris University Hospitals
  • Co-organizers:
  • Bo'ao Academy of Medical Innovation
  • Healthcare Management Committee, China Management Science of Society
  • Non-Government Medical Institutions Branch, Chinese Research Hospital Association
  • Non-profit Collaborator:
  • Wu Jieping Medical Foundation

Rising in the east of the world, China has put health agenda as its top priority. “Health in All” is the mission of this era.

In collaboration with Chinese Research Hospital Association and Health and Family Planning Commission of Hainan Province, the 6th CN-HEALTHCARE SUMMIT - China's first brand conference on hospital development and health industry, with a new name of “BO'AO · CN-HEATHCARE SUMMIT” will be held on April 25-28, 2018 in Bo'ao of Hainan Province, China, right after the highly reputable Bo'ao Forum for Asian 2018. We look forward to your participation!

In the “Healthy China 2030” blueprint, China's most influential policy issued in the 21st Century, people's health has been put in the highest position in history. In the 2016 National Health Conference of China, President Xi Jinping emphasized “Health in All Policies” (HiAP), which is not only China's commitment to the “2030 Agenda for Sustainable Development” of the United Nations, but also the mission of this era for the Chinese nation.

With health as the ultimate goal, China's medical and healthcare service system will re-organize all important resources, from politics to economics, from medicine to health; meanwhile, based on the uppermost respect for human life, the construction of a “people-oriented” culture will become the core value among all.

The health industry is booming in many fields across China, with science and technology, innovation, start-up and connectivity as its features, and taking the experiences and practices of the world's leading innovative countries as reference. The theories and practices of maintaining and protecting people's health from all dimensions and throughout the whole course of life will form an ecological pattern of the health industry, which is rich in contents, reasonable in structure, supportive for each other and with good outcomes. Such fields as artificial intelligence, robot, big data, internet of things (IOT), telemedicine, biologicals, western medicine and traditional Chinese medicine, precision medicine, urban development, aging and well-being industry, elderly care and health preservation, environment and ecology, etc. are all flourishing and showing promising prospects.

With public hospital reform as the fundamental, China's medical and healthcare services, characterized by diversity, continuity, accessibility and quality, are expecting the integration of various areas including regional planning, non-government medical institutions, health management, combination of medical and social care, hierarchical health care, medical alliances, discipline development, quality and safety, service improvement, financing and payment, smart health, scientific research translation, precision medicine, prevention and rehabilitation, overseas medicine, etc. Now is the very beginning of competitions and opportunities!

With the context of the above mentioned, the theme of this Summit is decided as: Health in All.

The Summit consists of 7 modules including “6 forums and 1 experiencing zone”: (1) Shangliang · Healthcare Investment and Financing Forum; (2) Chinese Non-Government Medical Institutions Conference; (3) China Medical Innovation Summit & CMIA Competition; (4) International Summit on Medical Quality and Safety & QCC Competition; (5) 21st Century Hospital CEOs Forum & China Hospital Management Award Competition; (6) Healthy China and Health Industry Development Summit; (7) Shangliang - Healthcare Innovation Experiencing Zone.

The venue of this Summit is the permanent site for BO'AO FORUM FOR ASIA. With its unique and beautiful environment, each year it receives a number of government leaders and economic celebrities from all over the world. A brand gathering is an ecologic platform.

The “BO'AO CN-HEALTHCARE SUMMIT 2018” will be remembered by history as “Health for All” begins right at this moment.

Adrienne Parrish Fuentes

Ms. Parrish Fuentes arrived in Beijing as the U.S. Department of Health and Human Services representative in February 2017. She is an experienced global health diplomat and international public health development professional who served at the U.S. Department of State in various capacities from 2002 to 2016. Most recently, Ms. Parrish Fuentes held a position with the Office of the U.S. Global AIDS Coordinator and Global Health Diplomacy as Senior Advisor for Finance, Accountability, and Oversight. From 2008 through 2013 she served as the Country Coordinator for the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) at the U.S. Embassy in Abuja, Nigeria and later at the U.S. Embassy in Windhoek, Namibia. Ms. Parrish Fuentes also has previous experience in the private consulting sector in the fields of health communication and energy security. Adrienne has an M.P.A. from the John F. Kennedy School of Government at Harvard University and a B.A. in International Relations and Japanese Studies from the University of Pennsylvania. She lives in Beijing with her husband and daughter.

Burak Malatyali

Vice President, Strategic Alliances and Global Services at NewYork-Presbyterian (NYP).
In this role, as a member of NYP’s Regional Hospital Network (RHN) leadership team, Burak leads NYP’s international efforts and strategic alliances function where he coordinates NYP’s regional growth and integration efforts in partnership with NYP’s Medical Group/Physician Services Organization and academic partners, Weill Cornell Medicine and Columbia University College of Physicians and Surgeons.
Prior to joining NYP, Burak served as the Executive Director for J.P. Morgan’s not-for-profit healthcare investment banking team exclusively focusing on strategic advisory and M&A services for number of health systems across the United States where he advised boards and senior executive leadership and led various growth, strategic options and transaction advisory engagements.

Bruno Gridelli

Executive Vice President, UPMC International Services
Professor of Surgery, University of Pittsburgh School of Medicine
As executive vice president of UPMC International, Dr. Bruno Gridelli supports the clinical and research aspects of UPMC’s international operations, contributing to the development of a network of collaborations and partnerships across the globe. He is a world-renowned expert in transplantation and has successfully transferred these clinical skills into various leading roles in hospital administration, such as director of Istituto Mediterraneo per I Trapianti e Terapie ad Alta Specializzazione.

Caroline Mascarenhas

Caroline is Vice President of Operations at the Houston Methodist Hospital, and has over 20 years of Leadership and Clinical experience. She has established multiple strategic initiatives to improve outcomes in Patient Care.
As the Medicine Service Line Leader, Caroline provides strategic leadership to Houston Methodist Hospital’s Physician Hospitalist Program, Emergency Departments, and in-patient Medicine units. She works closely with the Department of Medicine to ensure that hospital operations support the academic and clinical mission of the organization.

Chaim Martin

Chaim Martin is the head of the Economic Mission in the embassy of Israel in Beijing. He and his team assist Israeli companies to deal with the various regulation issues in China, and promote trade in heavily regulated sectors such as Life science related trade, Cosmetics and food supplements.
In addition Chaim and his team have been exposing Chinese investors to the Israeli Life Science sector and have made introductions that have led to significant deals in this sector.
Chaim was sent to China as a representative of Israel's ministry of Economy.

Jie Qiao

Jie Qiao,is Academician of Chinese academy of engineering,President and Chief Physician of Peking University Third Hospital, Director and Professor of Center for Reproduction Medicine. She has been working on reproductive biology and the pathology of infertility since 1990 and her reproductive research focus on the molecular mechanism of human gametogenesis and embryo development, infertility causes and clinical treatments, the protection and preservation of female fertility as well as assessing the safety of assisted reproductive technology and developing new pre-implantation diagnosis methods. Dr. Qiao’s team made many landmark contributions to the development of reproductive medicine. Her team award “National Prize for Progress in Science and Technology ”(Second Prize),“Progress Prize in Science and Technology of Education Ministry” (First Prize) and approved “National Clinical Research Center for Obstetrics & gynecology”, “key laboratory of Education Ministry” and etc. Her findings were published in The Lancet, JAMA, Cell, Nature, Nature Genetics and other leading journals, providing new insights into the mechanism of epigenetic regulation during embryonic development.

Hong Sun

Hong Sun, M.D., is a professor, chief physician and doctoral supervisor of Otolaryngology, Head and Neck Surgery and Social Medicine and Health Service Administration at Central South University (CSU). He is currently the president of Xiangya Hospital Central South University and the director of Hospital Administration Institute Central South University. He is also a research professor at Dept. of Communicative Disorders and Sciences, The State University of New York at Buffalo (SUNY at Buffalo) and a visiting professor at Dept. of Biochemistry & Molecular Biology, University of Texas Health Science Center Houston.

Guosheng Feng

The Council Chairman of Beijing Chao-yang Hospital, Doctor of Medicine, Professor, and Chief Physician. He is skilled in surgical management of tumor, especially the diagnosis and treatment of gastrointestinal tumors. He has served as the Director and Deputy Secretary of CPC of Beijing Railway General Hospital, the Director and Deputy Secretary of CPC of Beijing Shijitan Hospital, the Director and Deputy Secretary of CPC of Beijing Chao-yang Hospital, the Deputy Director of Beijing Municipal Commission of Health and Family Planning, the Director and Secretary of CPC of Beijing Municipal Administration of Hospitals. At present, he holds the positions of the Council Chairman and Secretary of CPC of Beijing Chao-yang Hospital, Capital Medical University; the Vice President of Beijing Health Insurance Association; the Vice Chairmen of the Tumor Branch of Beijing Medical Association; the Council Member of the Surgical Branch of Beijing Medical Doctor Association; the Council Member of Chinese Anti-Cancer Association.

Junbo Ge

The Academician of Chinese Academy of Sciences; the Director of the Department of Cardiology of Zhongshan Hospital, Fudan University; the Current Chairman of the Cardiology Branch of Chinese Medical Association; the Initiator of China Medical Innovation Alliance; the President of the Bo’ao Medical Innovation Research Institute; the Chairman of Asian Pacific Society of Interventional Cardiology; the International Adviser of American College of Cardiology. At present, he holds the positions of the Chief Physician, Professor, Ph.D. Student Adviser, Director of Department of Cardiology, Director of Cardiac Catheterization Room in Zhongshan Hospital, Fudan University; the Director of Shanghai Institute of Cardiovascular Diseases; the Special-appointed Professor of Chang Jiang Scholars Program; the Council Member of Research Institute of National Higher Medical Teaching Materials Construction; the Honorary Chairman of Chinesisch-Deutsche Gesellschaft für Medizin; the Chairman of International Chinese Heart Health Network; the Member of the Consultative Committee of International Cardiopathy Conference; the Member of Board of Trustee of American SCAI; and the Guest Professor of Germany Essen University, the Guest Professor of the University of Hong Kong.

John A. Crooks

Mr. Crooks began his career at Mayo Clinic in 1996 as a Senior Analyst Programmer in the Information Technology (IT) department. Since that time, he has held progressive management positions which include IT Manager, Director, and is currently an IT Division Chair. His responsibilities include IT support for the Cerner electronic medical record as well as IT support for Research, Education, Global Business Solutions, and Administrative Applications across the organization.
Prior to joining Mayo Clinic, Mr. Crooks was a program manager and software developer for two organizations in Silicon Valley, California. He has a total of 31 years of information technology experience and has been leading IT teams for the past 20 years.

Michael Stewart

Dr. Stewart received a B.E. degree summa cum laude from Vanderbilt University, and his M.D. from Johns Hopkins University School of Medicine. He completed residency training in General Surgery and Otolaryngology-Head and Neck Surgery at Baylor College of Medicine, and received his M.P.H. degree from the University of Texas School of Public Health. At Baylor College of Medicine after residency training, he served as Associate Professor and Director of Residency Education for the Department, Chief of Service at Ben Taub General Hospital, and Associate Dean of Clinical Affairs for the College, before coming to Weill Cornell. He is the author of 2 textbooks, as well as more than 30 book chapters and 110 peer-reviewed publications. Dr. Stewart has received many awards and honors, including the Fulbright and Jaworski Faculty Excellence Award while at Baylor College of Medicine, and he was inducted into the Academy of Distinguished Educators there.

Michael Bierl

Director, Strategic Alliances & Global Services for NewYork-Presbyterian Hospital (NYP)
In this capacity he directs domestic and global growth initiatives for NYP in collaboration with its academic partners Weill Cornell Medicine at Cornell University and Vagelos College of Physicians and Surgeons at Columbia University. His areas of focus include NYP’s regional hospital network and medical groups, partnerships with employers, international alliances and patient services, and digital health. Prior to coming to NYP, Michael worked for The Boston Consulting Group advising international healthcare corporations on strategic and operational matters. He also worked on a joint venture with Johns Hopkins Medicine translating a landmark clinical trial into a digital diabetes program. Michael is a member of the Catalyst Insights Council for the New England Journal of Medicine and acts as an advisor to several healthcare technology startups. Michael earned an MS in Health Economics from the London School of Economics and Political Science, UK, and a BS in Healthcare Management from the University of Bayreuth, Germany as a scholar of the German Academic Scholarship Foundation.

Tom C. Tomlinson

Tom C. Tomlinson joined Alliance HealthCare Services as Chief Executive Officer in October 2013. With more than 25 years of diverse executive management and leadership experience, Mr. Tomlinson’s experience spans the healthcare, consumer products, insurance, and airline industries. Prior to joining Alliance, Mr. Tomlinson served as the Chief Executive Officer for Midwest Dental. Previously, he spent 10 years with the Center for Diagnostic Imaging (CDI) in several senior roles including Chief Executive Officer, President and Chief Operating Officer, and Senior Vice President and Chief Financial Officer. During his tenure, he played a key role in CDI’s growth and development while creating the second-largest radiology and related services organization in the U.S. with the merger of Insight Imaging and CDI.

Timothy R. Billiar

George Vance Foster Professor and Chair, Department of Surgery, University of Pittsburgh
Vice-President and Chief Academic Officer, University of Pittsburgh Physicians
Associate Medical Director, UPMC International
During his career in healthcare administration, Jack held a variety of positions, including direct responsibility for strategic planning, hospital administration, health insurance operations management, physician practice management, clinical operations and business development.Dr. Billiar has worked to develop collaborative programs with Universities in China and in 2016 received the Friendship Award from the People’s Republic of China, the highest award bestowed by the government of China to foreigners making contributions to the Chinese people.

Shayn Carlson

As senior director of partnership development for Global Business Solutions (GBS) of Mayo Clinic, Mr. Carlson is responsible for the development and growth of strategic partnerships to help Mayo Clinic generate financial returns by extending its reach and driving targeted demand.
Mr. Carlson has extensive management experience in finance, communications, investor relations, marketing, business development and international operations from his work at Mayo Clinic, G&K Services, Pemstar, Inc. and Hutchinson Technology. Prior to his current position, he led Mayo Medical Laboratories client pricing team that served hospitals around the globe. Prior to joining Mayo, he was director of investor relations at G&K Services, where he was responsible for executing the company’s investor relations strategy. While at Pemstar, Inc. Mr. Carlson was executive director of finance and investor relations where he led multiple functions including financial analysis, strategic planning, treasury operations, investor relations and company expansion opportunities including acquisitions. Mr. Carlson holds Bachelor’s and Master’s degrees in business from Minnesota State University.

Shirly Coifman

Shirly Coifman is the Economic Consul and Head of Economic and Trade Mission to South China, located at the Consulate General of Israel in Guangzhou.
Shirly and her team work to strengthen the economic ties between Israel and China, by exposing Israeli companies to business opportunities in the Chinese market, facilitating economic collaboration between Chinese and Israeli technologies, and assisting Chinese Investors and Corporations to meet their needs in the Israeli innovative ecosystem.

Robert Edwards

He is the Milton Lawrence McCall Professor and Chair of the Department of Obstetrics, Gynecology and Reproductive Sciences at Magee-Womens Hospital of UPMC, Director of Transformational Medicine of UPMC, Tenured Professor & Vice Chair, Clinical Affairs of Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences at the University of Pittsburgh School of Medicine, and Senior Investigator Magee-Womens Research Institute.

Sharon R. Gabrielson

As Chair of Globla Business Solution of Mayo Clinic, Ms. Gabrielson is is a healthcare executive with over 20 years of broad-based leadership experience in strategic and operational planning, practice, quality improvement, outcomes, safety and service. These experiences have included executive level leadership of both small and large healthcare systems, management of integrated healthcare organizations, and integration of clinical practices, multidisciplinary organizations, and stakeholders.
Ms. Gabrielson is a member of many local and national committees for various organizations, is a published author, has made many presentations before various groups and is a member of the American Medical Group Association Board of Directors and the AMGA CAO Leadership Council.

Wen-Ta Chiu

Co CEO/Consultant, AHMC Healthcare Inc., CA, USA.
Board of Trustee, Allied Pacific IPA, U.S. A.
Chair Professor, Taipei Medical University, Taiwan
Chair Professor & Chairman of Academic Committee, National Tsing Hua University, China
Chairman of the Board, Foundation for Injury Prevention and Control, Taiwan
President, Taiwan Global Healthcare Association, Taiwan

Tingfangn Liu

Founder, and senior dean consultant (Vice-Dean Level) of Institute for Hospital Management, Tsinghua University, being in charge of researching (used to take charge of the general work) . Professor, PG Supervisor, Post-doc Supervisor, the Institute for Hospital Management, Tsinghua University. Director of International Hospital Review and Evaluation Centre, Institute for Hospital Management, Tsinghua University. Director of the Institute of Healthcare Management and Evaluation, Tsinghua University. Chairman of China Federation for Hospital Quality Management. ISQua Expert. Committee member of the Advisory Expert Committee on Reform and Development of Traditional Chinese Medicine, State Administration of Traditional Chinese Medicine. Deputy Director of the Expert Committee on Professionalization of the hospital CEO, NHFPC. Director of Evaluation and Appraisal Specialized Committee, China’s Research Hospital Association.

Steve R.Ommen

Dr. Steve R. Ommen is a Professor of Medicine, Mayo Clinic College of Medicine and Consultant in the Department of Cardiovascular Medicine. He serves as the Director of the Mayo Hypertrophic Cardiomyopathy Clinic, the largest and longest-standing dedicated HCM Center in the world. Mayo’s HCM clinic is recognized as a leader in clinical outcomes, research, and patient education. Dr. Ommen is also Co-director of the Structural Heart Disease program, Medical Director for AskMayoExpert, Associate Dean of the Center for Connected Care, and Medical Director(i), Mayo Global Business Solutions.

Martin Hirsch

Martin Hirsch, former minister in the French government, is the CEO of Greater Paris University Hospitals (AP-HP), the largest European academic hospital group, since 2013.
He held various positions within the French administration such as member of the council of State, chief of staff of the health minister, CEO of the French food safety agency.
He was member of the French Government between 2007 and 2010 as High commissioner for the policy against poverty and High commissioner for Youth, member of the council of ministers.

Wendy Nicklin

Wendy Nicklin, R.N., B.N., M.Sc.(A), CHE, FACHE, FISQua, ICD.D
A valued active partner in discussions about improving the quality of health care, Wendy is a recognized health care leader across Canada and internationally. Obtaining her academic degrees at McGill University, Wendy has extensive experience as a critical care nurse and in progressive leadership positions. She has participated in many provincial and national initiatives, such as the National Steering Committee for Patient Safety, and as a founding Board member on the Canadian Patient Safety Institute Board for 8 years, working to contribute to its establishment and success. After over 11 years at the helm, Wendy recently stepped down from the position of President and Chief Executive Officer of Accreditation Canada. She led a significant renewal of the approach to and value of accreditation. Her global leadership about accreditation is well regarded.

In addition to the ISQua board, she serves on several other boards including the Healthcare Insurance Reciprocal of Canada (HIROC) and the Champlain Local Integration Health Network (LHIN). She is a member of the Institute of Corporate Directors (ICD) and recently completed the ICD-Rotman Directors Education Program. An Emeritus member of CHLNet, she chairs the CHLNet Knowledge Mobilization Working Group.

Within the International Society for Quality in Health Care (ISQua), and after 7 years on the ISQua Board, Wendy is now President-elect. She is Past-Chair of the ISQua Accreditation Council for the International Accreditation Program, member of the Innovation and Systems Change working Group, Chair of the Board Accreditation Committee, an Expert, a Fellow and an ISQua surveyor.

Wendy received the Woman of Distinction Award – Health Services in 1999, the Canadian Nurses Association Centennial Award in 2008, the CCHL Eastern Ontario Chapter Award for Distinguished Service in 2012, and the University of Ottawa Telfer School of Management Preceptor award for 2016. With a strong commitment to effective governance and focusing on quality, safety and leadership, Wendy has numerous publications to her name and has given many presentations nationally and internationally. She has an academic appointment to Queen’s University.

Yuichi Imanaka

Yuichi Imanaka, MD, PhD is Professor and Head, Department ofHealthcare Economics and Quality Management, Graduate School of Medicine/School of Public Health, Kyoto University (http://med-econ.umin.ac.jp/int/) since 2000. He was trained in the University of Tokyo (M.D., DrMedSci), and the University of Michigan (MPH, Ph.D). Board certified member of the Japanese Society of Internal Medicine, with certification for pathological autopsy practice. He is the founding head of the Value Creating Design Hub for Super-Ageing Societies, Kyoto University (http://super-ageing.kyoto-u.ac.jp/), which started in 2016 as a multidisciplinary unit of Industry-Government-Academia partnership.

Focusing on quality and efficiency of health care, his main theme is to visualize and design health systems covering health care, long-term care, health promotion, and its future, particularly in this super-aged and rapidly-aging society. He is engaged in several national and wide-regional projects which methodologically include large-scale database analytics, system design and simulation, and multidimensional performance and quality measurement and improvement of institutions and of regions.

In Japan, he has been devoted himself to setting up and development of quality improvement systems, including quality management system and quality measurement. He has been the executive board member for Japan Council for Quality Health Care (2000-current), is also on the boards of national academic societies for Health Administration, Public Health and Health Economics, and is founding team leader and the vice president of Japan Board of Public Health and Social Medicine.

He is Executive Board Member (1997-2003, 2015-current) for the International Society for Quality in Health Care (ISQua), President (2017-2018) of the Asian Society for Quality in Health Care (ASQua).

Shin Ushiro

Prof Shin Ushiro currently serves as Director, Executive Board Member of the Japan Council for Quality in Health Care (JCQHC) and General Manager of the Division of Adverse Event Prevention which have carried out a nationwide adverse event reporting system. He is also a Professor of the Division of Patient Safety Management at Kyushu University, Japan and a Technical Supervisor of the division of the Japan Obstetric Compensation System for Cerebral Palsy which is a no-fault-based compensation system with in-depth investigation on Cerebral Palsy.

Prof Ushiro graduated from Kyushu University School of Medicine and has accumulated such experience as a surgeon, researcher on basic science, government official and so on. Prof Ushiro still works as a physician in a hospital which is a most suitable field for him to see if technical and educative materials in such projects as adverse event reporting systems effectively works for medical professionals in the front line of clinical practices. Prof Ushiro’s wide spectrum of career and perspective are so unique and beneficial to tackle with future challenges of ageing society and advanced medicine.

Bhupendra Kumar Rana

Dr. B.K. Rana is the Founding CEO of Quality & Accreditation Institute (QAI) and former Director of NABH, Quality Council of India. He served International Society for Quality in Health Care (ISQua) as elected Vice-Chairman- Accreditation Council (2008-2014) and Chairman- Accreditation Council (2014-2016). He was appointed Director on ISQua Board from 2014 to 2016. Concurrently, he served as President of Asian Society for Quality in Healthcare (ASQua) in 2011 & 12 and now serving as Director on its Board and Chairman- Technical Committee. He has many honours to his credit including an appointment as ‘ISQua Expert’. Because of his unparalleled mastery and knowledge, he took part in WHO’s International Steering Committee for Patient Safety and served also as External Consultant of World Health Organization (WHO) on setting hospital accreditation program. Alongside, he achieved rare distinction by becoming part of United Nations Framework Convention on Climate Change (UNFCCC) as an Expert/Assessor for Clean Development Mechanism (CDM). He sits on many national and international committees including ISO/ TC 210 WG1.
His expertise on Standardisation, Quality, and Accreditation include establishing accreditation bodies [Laboratory (ISO/IEC 17011) and Healthcare Providers (ISQua)], External Quality Assessment Schemes (ISO/IEC 17043), Standard Development, Training Program Development, Implementation of the Requirements of ISO/IEC 17025, ISO 15189 and ISO/IEC 17043. He is sought-after as a speaker and is published in several magazines on accreditation, quality improvement, patient safety, standards etc.

Dr. Rana holds Ph.D in Biochemistry & Diploma in German. He also received Post Graduate Diploma in Hospital and Health Management. He has published nine research papers in international journals, contributed chapters in books and presented in several national and international conferences

David Greenfield

Professor David Greenfield is the Director of the Australian Institute of Health Service Management (AIHSM), University of Tasmania, Australia. The AIHSM, based in Sydney, is dedicated to improving the quality and efficiency of healthcare by: educating professionals to lead, manage, and innovate in increasingly complex organisational and clinical environments; and conducting collaborative research projects. David’s educational and research work is at the intersection of improvement and implementation sciences. He investigates healthcare complex adaptive systems, health services and the organisation of clinical practice. Within and across these spheres David examines what impacts on quality improvement, how to achieve efficiencies in systems and mechanisms to integrate research findings and evidence into healthcare policy and practice. This includes, for example, the formal or informal management and regulation of the organisation and delivery of care, via accreditation programs, organisational processes and policy or inter-professional collaboration strategies. The purpose of David’s educational and research endeavours is to derive evidence to improve organisational functioning, service delivery mechanisms, staff and patient engagement and patient outcomes.
David is a Fellow of the International Society for Quality in Health Care (ISQua) and a Fellow of the Australasian Association for Quality in Health Care. He is a recognised as an ISQua Expert. David is a Deputy-Editor for the ISQua journal, The International Journal for Quality in Health Care.

David Vaughan

Director of Quality and Patient Safety, Children’s Hospital Group comprising three Dublin children's hospital, & a Consultant Respiratory Paediatrician. He previously was the Executive Director and Clinical Director of Q&S for Hamad Medical Corporation, the national health system of the State of Qatar 2013- 2016. Dr. Vaughan was the Director for Leadership & Quality in RCPI, responsible for developing and delivering a Diploma in Leadership and Quality in Healthcare, directed at senior healthcare staff, (clinical & nonclinical) & led in the development of the National Quality Improvement Programme jointly with the DoH, the HSE & RCPI. He graduated from UCD in 1992, undertook general paediatric training in Dublin, & trained in paediatric critical care medicine in Seattle Children’s Hospital and paediatric respiratory medicine in Texas Children’s Hospital, Ho

Ezequiel Garcia Elorrio

Dr. Ezequiel Garcia Elorrio obtained his Medical Degree from the University of Buenos Aires and he then specialised in Internal Medicine at the Centre for Medical Education and Clinical Investigation (CEMIC). Dr. Garcia Elorrio is W.K. Kellogg Foundation Fellow and he attended the Harvard School of Public Health in Boston MA, USA where he obtained a Master’s degree in Epidemiology. Dr. Garcia Elorrio also studied at School of Business from Austral University where he earned a Master’s degree in Business Administration. Finally Dr. Garcia Elorrio obtained a PhD in Medicine from the University of Buenos Aires.

Dr. Garcia Elorrio is currently Director of Quality in Health Care and Patient Safety Department at the Institute for Clinical Effectiveness and Health Policy in Buenos Aires, Argentina. He has participated in educational research and consultancy projects in Argentina, the LAC region and globally in quality improvement, patient safety and external evaluation. He has special interest in research adapted solutions, quality improvement, patient reported outcomes and professional behavioural change.

Policy Dividend:

Rising of New Medical Institutions (DONGYU GRAND BALLROOM A, BOAO FORUM FOR ASIA)

Precision Medicine:

Opportunities in an Era of Personalized Health (DONGYU GRAND BALLROOM B, BOAO FORUM FOR ASIA)

Smart Healthcare:

Prospects of the Internet of Things (IoT) (DONGYU GRAND BALLROOM C, BOAO FORUM FOR ASIA)

Private Classroom for CEOs:


  • 2018 BO'AO CN-Healthcare Summit

  • 2018 BO'AO CN-Healthcare Summit
    for groups with more than 10 persons

About the ticket:

1. Please ensure you have left your cellphone number, cause all information during the summit will be delivered through text message.

2. The through ticket covers all modules, but it does not cover any accommodation fees. You can contact the organizing committee to make reservation.

3. In case you cannot attend the summit, please inform the organizing committee a week ahead of the summit, otherwise you will only receive 50% refund.

4. This summit is abundant in topics, and it is suggested an organization send several delegates.

Venue and the hotel address:

Bo'Ao Forum for Asia International Conference Center / Bo'Ao Forum for Asia Hotel: No. 1, Yuanyang Road, Dongyu Island, Bo'Ao County, Qionghai, Hainan Province, China

BFA Dongyu Island Hotel(the site of Shangliang VIP Meeting & Closed-door Roadshow, Chinese Non-Government Medical Institutions Conference and Healthy China and Health Industry Development Summit)No. 2, Yuanyang Road, Dongyu Island, Bo'Ao County, Qionghai, Hainan Province, China

The two hotels are about 400 meters far, and they are 15 kilometers from (about 30 minutes' drive) Qionghai Bo'Ao Airport.

Accommodation fees:

Bo'Ao Forum for Asia Hotel: Superior Twin Room/King Room: 650 RMB/Room/Night

BFA Dongyu Island Hotel: Garden View Twin Room/King Room: 550 RMB/Room/Night

The summit hotel only has a limited number of rooms, if you want to make a reservation, please send the registration fee and accommodation fee to the allocated account before April 15. (If all rooms are booked, those rooms without accommodation fee will not be reserved.) The organizing committee is only in charge of reservations of the summit duration (April 25-April 28).

If you have any questions, please contact us:

Contacts: Ye Doudou (Ms.)

E-mail: yedoudou@hmkx.cn

Mobile: +86 139 1125 5640

©2012 Beijing CN-Healthcare Information & Technology Co.,Ltd. All Rights Reserved. Registered Office:Beijing Tele:82736610

京ICP证150092号 京公网安备 11010802020745号